Ligand Pharmaceuticals (LGND) Inventory Average (2011 - 2026)

Ligand Pharmaceuticals has disclosed Inventory Average across 16 years of filings, most recently posting $11.2 million for Q1 2026.

• Inventory Average for Q1 2026 came in at $11.2 million, down 22.06% year-over-year; the trailing twelve-month figure through Mar 2026 was $11.2 million (down 22.06% YoY), and the FY2025 annual result was $11.6 million, down 38.98% from the prior year.
• Inventory Average came in at $11.2 million for Q1 2026 at Ligand Pharmaceuticals, up from $10.5 million in the prior quarter.
• In the past five years, Inventory Average ranged from a high of $26.5 million in Q1 2022 to a low of $10.5 million in Q4 2025.
• The 5-year median for Inventory Average is $17.8 million (2022), against an average of $18.7 million.
• Across the five-year window, Inventory Average plunged 48.42% in 2023 and soared 65.93% in 2024, its largest moves.
• Ligand Pharmaceuticals' Inventory Average stood at $17.8 million in 2022, then jumped by 38.58% to $24.7 million in 2023, then sank by 37.49% to $15.4 million in 2024, then tumbled by 31.85% to $10.5 million in 2025, then advanced by 6.5% to $11.2 million in 2026.
• The last three Inventory Average figures came in at $11.2 million (Q1 2026), $10.5 million (Q4 2025), and $13.7 million (Q3 2025), per Business Quant data.